Search

Dengue fever has become an imminent threat to international public health because of global warming and climate change. The World Health Organization proclaimed that more than 50% of the world’s population is at risk of dengue virus (DENV) infection. Therefore, developing a clinically ap-proved vaccine and effective therapeutic remedy for treating dengue fever is imperative. Peptide drug de-velopment has become a novel pharmaceutical research field. This article reviews various peptides-based antimicrobial agents targeting three pathways involved in the DENV lifecycle. Specifically, they are peptide vaccines from immunomodulation, peptide drugs that inhibit virus entry, and peptide drugs that interfere with viral replication. Many antiviral peptide studies against DENV have been conducted in animal model trials, and progression to clinical trials for these promising peptide drugs is anticipated.

Although vaccines and antibiotics could kill or inhibit microbes, many infectious diseases remain difficult to treat because of acquired resistance and adverse side effects. Nano-carriers-based technology has made significant progress for a long time and is introducing a new paradigm in drug delivery. However, it still has some challenges like lack of specificity toward targeting the infectious site. Nano-carriers utilized targeting ligands on their surface called ‘active target’ provide the promising way to solve the problems like accelerating drug delivery to infectious areas and preventing toxicity or side-effects. In this mini review, we demonstrate the recent studies using the active targeted strategy to kill or inhibit microbes. The four common nano-carriers (e.g. liposomes, nanoparticles, dendrimers and carbon nanotubes) delivering encapsulated drugs are introduced.

Bacterial and cancer cells that are resistant to current specific therapy have become an increasingly important public health problem over the past several decades. Consequently, the search for new anti-infection and anti-cancer treatments of drug resistant microbes has attracted a lot of attention. Recently, nanostructures have been shown to be efficient antimicrobial agents that do not induce drug-resistance. The present study reviews the advances in anti-pathogenic bio-hybrid nanostructures over the past decade. Three important issues are presented and discussed. First, the review focuses on the anti-pathogenic activity of the most common types of metallic / metal oxide nanoparticles. It not only reviews the progress of antimicrobial characteristics for various types of nanoparticles under different fabrication processes, but it also tabulates some specific findings over the past decade. Secondly, it reviews the use of polymeric, gold and iron-oxide nanoparticles as effective chemotheraputic drug carriers or for gene transduction in cancer treatment. Finally, some new advances made in Taiwan in anti-pathogenic research using nanotechnology were addressed in brief at the end of this paper. We highlighted the advances of the photo-controlled targeted drug-delivery system and the development of nanoparticles of traditional Chinese herbs, both of which representing important milestones in the last decade.